{"Symbol": "CUTR", "AssetType": "Common Stock", "Name": "Cutera, Inc", "Description": "Cutera, Inc., a medical device company, engages in the research, development, manufacture, marketing, and servicing of laser and energy-based aesthetics systems for practitioners worldwide. The company offers truSculpt flex, a bio-electrical muscle stimulation device to treat patients at all fitness levels; truSculpt for the non-surgical body sculpting market; Juliet, a laser for women's intimate health; Secret RF, a fractional radio frequency microneedling device for skin revitalization; and enlighten platform, a laser system that is used for tattoo removal, as well as for the treatment of benign pigmented lesions and acne scars. It also provides excel HR platform, a hair removal solution for various skin types; excel V+, a vascular and benign pigmented lesion treatment platform; and xeo platform, a multi-application platform on which a customer purchases hand piece applications for the removal of unwanted hair, treatment of vascular lesions, and skin revitalization by treating discoloration, fine lines, and laxity. In addition, the company offers GenesisPlus, CoolGlide, and myQ products. Further, it provides pulsed light hand pieces for the treatment of discoloration, hair removal, and vascular treatments; Pearl and Pearl Fractional hand pieces; and post-warranty services through extended service contracts or direct billing, as well as offers Titan hand piece refills, cycle refills, consumable tips, and marketing brochures through the company's website cutera.com. The company markets and sells its products through direct sales force to plastic surgeons, dermatologists, gynecologists, family practitioners, primary care physicians, and other qualified practitioners, as well as for physicians performing aesthetic treatments in non-medical offices. Cutera, Inc. was founded in 1988 and is headquartered in Brisbane, California.", "Exchange": "NASDAQ", "Currency": "USD", "Country": "USA", "Sector": "Healthcare", "Industry": "Medical Devices", "Address": "3240 Bayshore Boulevard, Brisbane, CA, United States, 94005", "FullTimeEmployees": "447", "FiscalYearEnd": "December", "LatestQuarter": "2020-06-30", "MarketCapitalization": "297863040", "EBITDA": "-12735000", "PERatio": "None", "PEGRatio": "9.05", "BookValue": "2.988", "DividendPerShare": "None", "DividendYield": "0", "EPS": "-2.491", "RevenuePerShareTTM": "10.475", "ProfitMargin": "-0.1822", "OperatingMarginTTM": "-0.1661", "ReturnOnAssetsTTM": "-0.1468", "ReturnOnEquityTTM": "-0.5962", "RevenueTTM": "156520000", "GrossProfitTTM": "98163000", "DilutedEPSTTM": "-1.913", "QuarterlyEarningsGrowthYOY": "0", "QuarterlyRevenueGrowthYOY": "-0.448", "AnalystTargetPrice": "18.75", "TrailingPE": "0", "ForwardPE": "0", "PriceToSalesRatioTTM": "1.6258", "PriceToBookRatio": "5.7072", "EVToRevenue": "1.7123", "EVToEBITDA": "0", "Beta": "1.5044", "52WeekHigh": "39.15", "52WeekLow": "9.07", "50DayMovingAverage": "14.5254", "200DayMovingAverage": "15.048", "SharesOutstanding": "17593800", "SharesFloat": "17160111", "SharesShort": "760620", "SharesShortPriorMonth": "553774", "ShortRatio": "2.52", "ShortPercentOutstanding": "0.03", "ShortPercentFloat": "0.0349", "PercentInsiders": "3.492", "PercentInstitutions": "82.298", "ForwardAnnualDividendRate": "0", "ForwardAnnualDividendYield": "0", "PayoutRatio": "0", "DividendDate": "None", "ExDividendDate": "None", "LastSplitFactor": "None", "LastSplitDate": "None"}